VSN16R

· Canbex Therapeutics Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VSN16R, covering 2018-03-02 to 2018-03-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of VSN16R for the Treatment of Spasticity in Multiple Sclerosis [Phase 2]